Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
Baxter
Medtronic
Boehringer Ingelheim

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for AZITHROMYCIN

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Payment Methods and Pharmacy Types for AZITHROMYCIN (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $42,157,258
INSIDE ANOTHER STORE $54,196,405
[disabled in preview] $225,575,236
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 906,118
INSIDE ANOTHER STORE 2,981,378
[disabled in preview] 8,696,335
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $27,793,205
MEDICARE $78,038,696
[disabled in preview] $217,856,378
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AZITHROMYCIN
Drug Units Sold Trends for AZITHROMYCIN

Annual Sales Revenues and Units Sold for AZITHROMYCIN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
AZITHROMYCIN   Start Trial   Start Trial 2017
AZITHROMYCIN   Start Trial   Start Trial 2016
AZITHROMYCIN   Start Trial   Start Trial 2015
AZITHROMYCIN   Start Trial   Start Trial 2014
AZITHROMYCIN   Start Trial   Start Trial 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
Dow
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.